Fatal acute haemopericardium associated with rivaroxaban in a patient with non-valvular atrial fibrillation

被引:0
|
作者
Omer, Siddiq [1 ]
Magezi, Frederick [2 ]
Patel, Martyn [3 ]
Alsawaf, Ali [4 ]
机构
[1] James Paget Univ Hosp, ST4 Geriatr, Great Yarmouth, England
[2] Queen Elizabeth Hosp, ST4 Geriatr, Kings Lynn, England
[3] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[4] Queen Elizabeth Hosp, Kings Lynn, England
关键词
Rivaroxiban; Haemopericardium; Fatal; Older people;
D O I
10.1093/ageing/afz070
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
An 82-year-old female was admitted with chest pain and non-specific T wave changes on her ECG. After 72 hours of conservative management she deteriorated with non-specific symptoms including nausea and a single episode of vomiting. Abdominal and Chest X-rays were unremarkable, blood tests showed worsening Acute Kidney Injury (AKI) on Chronic Kidney Disease (CKD); and raised C-Reactive Protein (CRP) with no obvious symptoms or focus of infection. She rapidly deteriorated going into asystole cardiac arrest and attempts at resuscitation failed. Post-mortem examination suggested the most likely cause of death was acute spontaneous Haemopericardium due to Rivaroxaban therapy which she was on for non-valvular Atrial Fibrillation (AF). We believe that this might be the first reported mortality with Rivaroxaban-associated spontaneous haemopericardium in the UK.
引用
收藏
页码:758 / 760
页数:3
相关论文
共 50 条
  • [41] DISTRIBUTION OF THROMBOEMBOLISM IN VALVULAR COMPARED TO NON-VALVULAR ATRIAL FIBRILLATION
    Ketha, Siva S.
    McBane, Robert
    Grill, Diane
    Mehta, Ramila
    Wysokinski, Waldemar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A368 - A368
  • [42] Distribution of thromboembolism in valvular versus non-valvular atrial fibrillation
    Blustin, Jodi M.
    McBane, Robert D.
    Ketha, Siva S.
    Wysokinski, Waldemar E.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (10) : 1129 - 1132
  • [43] Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation
    Kelliher, Sarah
    Weiss, Luisa
    Szklanna, Paulina
    Egan, Karl
    Prendiville, Tadhg
    Moran, Eric
    Petrov, Georgi
    Blanco, Alfonso
    Lennon, Aine
    Murphy, Sean
    Keaney, John
    Ainle, Fionnuala Ni
    Maguire, Patricia
    [J]. BLOOD, 2019, 134
  • [44] Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis
    Ashley Prentice
    Irene Ruiz
    Erin R. Weeda
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 49 : 360 - 364
  • [45] Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Thomson, Erin
    Smith, David M.
    Coleman, Craig I.
    Damaraju, C. V.
    Schein, Jeffrey R.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (10) : 1831 - 1840
  • [46] Therapeutic compliance with rivaroxaban in preventing stroke in patients with non-valvular atrial fibrillation: CUMRIVAFA study
    Marquez-Contreras, Emilio
    Martell-Carlos, Nieves
    Gil-Guillen, Vincente
    De la Figuera-Von Wichmann, Mariano
    Sanchez-Lopez, Eugenio
    Marquez-Rivero, Sara
    Gil-Gil, Ines
    Hermida-Campa, Enrique
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (12) : 2013 - 2020
  • [47] Population Pharmacokinetics of Rivaroxaban in Chinese Patients with Non-Valvular Atrial Fibrillation: A Prospective Multicenter Study
    Feilong Zhang
    Xuehai Chen
    Tingting Wu
    Nianxu Huang
    Li Li
    Dongdong Yuan
    Jing Xiang
    Na Wang
    Wenjun Chen
    Jinhua Zhang
    [J]. Clinical Pharmacokinetics, 2022, 61 : 881 - 893
  • [48] Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
    Kim, Chi Kyung
    Jung, Seunguk
    Yoon, Byung-Woo
    [J]. JOURNAL OF STROKE, 2013, 15 (03) : 144 - 152
  • [49] Factors Associated with Outcome in Stroke Patients with Non-Valvular Atrial Fibrillation
    Maruyama, Kenji
    Shiga, Tsuyoshi
    Iijima, Mutsumi
    Uchiyama, Shinichiro
    Kitagawa, Kazuo
    [J]. CEREBROVASCULAR DISEASES, 2014, 38 : 65 - 66
  • [50] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Norby, Faye L.
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Chamberlain, Alanna M.
    Rapson, Ian
    Alonso, Alvaro
    [J]. BMC CARDIOVASCULAR DISORDERS, 2017, 17